0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Letters |

Treatment of Familial Mediterranean Fever with Anakinra

Rakiba Belkhir, MD; Luc Moulonguet-Doleris, MD; Eric Hachulla, MD, PhD; Jacques Prinseau, MD; Alain Baglin, MD; and Thomas Hanslik, MD, PhD
[+] Article and Author Information

From Hôpital Ambroise Paré, Boulogne 92104, France.


Potential Financial Conflicts of Interest: None disclosed.


Ann Intern Med. 2007;146(11):825-826. doi:10.7326/0003-4819-146-11-200706050-00023
Text Size: A A A

Figures

Grahic Jump Location
Figure. The patient was receiving colchicine, 1 mg/d, until 9 June 2005, when the dosage was increased to 1.5 mg/d through 8 November 2005, when the treatment was stopped. From 29 November 2005, colchicine treatment was introduced again at a dosage of 0.5 mg/d. Anakinra treatment, 100 mg every other day, was started at the same time, was increased to 100 mg/d between 28 December 2005 and 21 April 2006 and from July 2006. From 21 April to July 2006, the patient did not receive anakinra. *Anakinra treatment started. †Anakinra treatment stopped. ‡Anakinra treatment restarted.
C-reactive protein (CRP) and serum amyloid A (SAA) values at baseline and their improvement during anakinra treatment.
Grahic Jump Location

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)